跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺倍戈 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Darolutamide Tablets
Approved
化学药品
Darolutamide Tablets
BAYER HEALTHCARE PHARMACEUTICALS INC.
🇨🇳 National Medical Products Administration
Approval Date
Sep 3, 2025
Approval ID
887ldOdKIsl
Company
BAYER HEALTHCARE PHARMACEUTICALS INC.
Type
化学药品
Approval Details
Approval Id
887ldOdKIsl
Approval Number
国药准字HJ20210010
Generic Name
达罗他胺片
Generic Name En
Darolutamide Tablets
Trade Name
诺倍戈
Drug Type
化学药品
Dosage Form
片剂
Strength
300mg
Reg Date
2025-09-03
Expired Date
2030-09-02
Company Name
BAYER HEALTHCARE PHARMACEUTICALS INC.
Company Detail Path
/organization/bayer-healthcare-pharmaceuticals-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 3, 2025
Approval ID
887ldOdKIsl
Type
化学药品
Back to NMPA Approvals